Laboratory Testing for Whooping Cough (Pertussis)
For suspected whooping cough, order a nasopharyngeal aspirate or Dacron swab for culture as the definitive diagnostic test, and consider PCR testing when clinical criteria are met (cough >2 weeks with paroxysms, whooping, or post-tussive vomiting) for faster results. 1
Primary Diagnostic Tests
Nasopharyngeal Culture (Gold Standard)
- Culture is the only certain way to confirm pertussis diagnosis and remains essential despite limitations 2
- Collect specimen using nasopharyngeal aspirate or Dacron swab from the posterior nasopharynx 2, 1
- Culture is 100% specific but has variable sensitivity (25-60% in practice) 2, 1
- Requires enriched media and takes 1-2 weeks for definitive results 1
- Critical timing consideration: Sensitivity drops dramatically after 2-3 weeks of cough (only 1-3% sensitive after 3 weeks) 1
- Sensitivity also decreases with prior antimicrobial treatment or previous pertussis vaccination 1
- Culture remains indispensable for antimicrobial susceptibility testing and molecular subtyping 1
PCR Testing (Rapid Alternative)
- PCR has higher sensitivity (80-100%) compared to culture and provides faster turnaround time 2, 1
- The CDC endorses PCR only when the clinical case definition is met: cough >2 weeks with paroxysms, inspiratory "whoop," or post-tussive vomiting 1
- PCR is 2-3 times more likely than culture to detect B. pertussis when classic symptoms are present 1
- Important caveat: PCR assays lack universal standardization and validation for routine clinical testing 2
- Most reliable during the first 2-3 weeks of illness (catarrhal phase) 3
Serologic Testing (Limited Role)
Paired Sera Testing
- Order paired acute and convalescent sera to demonstrate a fourfold increase in IgG or IgA antibodies to pertussis toxin (PT) or filamentous hemagglutinin (FHA) 2
- First serum sample should be collected within 2 weeks of cough onset, second sample 3-4 weeks later 2
- Reported specificity and sensitivity are 99% and 63%, respectively, for documenting community outbreaks 2
- Major limitation: Patients often delay seeking care, making paired samples impractical for clinical diagnosis 2
- Serology becomes more useful after 2-3 weeks when culture/PCR sensitivity declines 3
Single-Sample Serology (Not Recommended)
- The CDC does not endorse single-sample serologic testing for routine diagnostic use because these assays lack standardization and cannot differentiate between recent disease, remote disease, or vaccination 4
- No FDA-licensed serologic assays exist for routine pertussis diagnosis in the United States 4
- IgM testing is not mentioned as a diagnostic tool in ACCP guidelines 3
Diagnostic Algorithm
When to Test
- Begin testing as early as possible in the illness course 1
- Suspect pertussis when cough lasts >2 weeks without another apparent cause, accompanied by paroxysms, post-tussive vomiting, and/or inspiratory whooping sound 1
Testing Strategy
- First-line: Order nasopharyngeal culture for all suspected cases 2
- Concurrent: Add PCR if clinical criteria are met and rapid diagnosis is needed 1
- Alternative: Consider paired sera testing for retrospective confirmation when culture/PCR are negative but clinical suspicion remains high 2
Confirmed Diagnosis Criteria
A confirmed diagnosis requires one of the following 1:
- Isolation of B. pertussis from nasopharyngeal culture
- Clinical case with PCR confirmation
- Clinical case with epidemiologic linkage to a confirmed case
Critical Clinical Pitfalls
- Do not delay treatment while awaiting test results 1
- Early treatment within the first 2 weeks rapidly clears B. pertussis from the nasopharynx and decreases coughing paroxysms 1, 3
- Isolate patients for 5 days after starting antibiotic therapy 1, 3
- Culture sensitivity is highest in the first 2 weeks of illness; after 3 weeks, culture becomes nearly useless 1
- Avoid relying on single-sample serology, as it cannot distinguish between infection and vaccination 4